Loading provider…
Loading provider…
Dermatology Physician in San Diego, CA
NPI: 1255349288Primary Practice Location
Tcr Medical Corporation
9025 Balboa Ave, San Diego, CA
Primary Employer
Tcr Medical Corporation
thecompanionship-registry.com
HQ Phone
Get Dr. Neal's Phone Numberphone_androidMobile
Get Dr. Neal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWI State Medical License
CA State Medical License
CA State Medical License
1998 - 2026
WI State Medical License
1994 - 2025
AZ State Medical License
2003 - 2011
IA State Medical License
1998 - 2001

American Board of Dermatology
Dermatology
Medical College Of Wisconsin
mcw.edu
Residency • Dermatology
1995 - 1998
Residency • Internal Medicine
1993 - 1995
University of Wisconsin–Madison
med.wisc.edu
Medical School
Until 1993
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 32 | 43 |
| 2 | 99212Established patient outpatient visit, total time 10-19 minutes | 13 | 20 |
| 3 | 17000Destruction of skin growth | 13 | 15 |
| 4 | 99203New patient outpatient visit, total time 30-44 minutes | 15 | 15 |
Authors: April Armstrong, Neal Bhatia, Andrew Blauvelt
Journal: Dermatol Ther (Heidelb)
Publication Date: 2022-09-24
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: J Am Acad Dermatol
Lead Sponsor: Verrica Pharmaceuticals Inc.
Collaborators: Q2 Solutions, Instat Clinical Research, HeartcoR Solutions, Myonex, Vial Health Technology, Inc, OncoBay Clinical, Canfield Scientific, Veristat
Intervention / Treatment: DRUG: Part 1: VP-315 3 Day Dosing/Week, DRUG: Part 2: VP-315 3 Day Dosing/Week - Loading Dose, DRUG: Part 2: VP-315 3 Day Dosing/Week - No Loading Dose, DRUG: Part 2: VP-315 2 Day Dosing/Week - Split Dose, DRUG: Part 2: VP-315 3 Day Dosing/Week - Split Dose
Lead Sponsor: Takeda
Intervention / Treatment: DRUG: Placebo, DRUG: Apremilast, DRUG: TAK-279
Lead Sponsor: Nutraceutical Wellness Inc.
Intervention / Treatment: DIETARY_SUPPLEMENT: Nutrafol® Men Hair Growth Nutraceutical, OTHER: Placebo Supplement